Sarilumab

Introduction: What is Sarilumab?

Sarilumab is a prescription medication used to treat moderate to severe rheumatoid arthritis (RA) in adults who have had an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs (DMARDs). It belongs to a class of drugs known as interleukin-6 (IL-6) inhibitors, which help reduce inflammation in the body. By targeting specific pathways involved in the immune response, sarilumab aims to alleviate symptoms and improve the quality of life for individuals suffering from this chronic autoimmune condition.

Uses of Sarilumab

Sarilumab is primarily approved for the treatment of:

• Rheumatoid Arthritis: It is indicated for adults with moderate to severe RA who have not responded adequately to one or more disease-modifying antirheumatic drugs (DMARDs).
• Other Conditions: While its main approved use is for RA, sarilumab has also been studied in other inflammatory conditions in clinical research. These uses are not currently established or routinely recommended.

How Does It Work?

Sarilumab works by blocking the interleukin-6 (IL?6) receptor, which reduces the activity of IL?6, a protein that plays a significant role in the inflammatory process. In rheumatoid arthritis, the immune system mistakenly attacks the joints, leading to inflammation, pain, and damage. By inhibiting IL-6, sarilumab helps reduce this inflammation, thereby alleviating symptoms such as pain and swelling, and slowing the progression of joint damage.

Dosage and Administration

Sarilumab is administered via subcutaneous injection. The recommended starting dose for adults is 200 mg once every two weeks. Based on response and tolerability, the dose may be reduced to 150 mg every two weeks. Dose strengths and adjustments may vary by country; follow your prescriber?s instructions.

Sarilumab is not routinely used for rheumatoid arthritis in children. If considered in pediatric patients for any reason, dosing would need to be determined by a specialist based on the child?s condition and weight. It is essential to follow the prescribed dosage and schedule to ensure the medication's effectiveness.

Side Effects of Sarilumab

Like all medications, sarilumab can cause side effects. Common side effects include:

• Injection site reactions (redness, swelling, pain)
• Upper respiratory infections
• Headache
• Nausea

Serious side effects may include:

• Serious infections (because sarilumab can weaken the immune system)
• Severe decreases in white blood cells or platelets
• Liver enzyme elevation and liver problems
• Gastrointestinal perforations
• Serious allergic reactions (hypersensitivity)

Your healthcare provider will perform regular blood tests to monitor blood cell counts and liver function during treatment.

Drug Interactions

Sarilumab may interact with several medications, including:

• Other immunosuppressants (e.g., methotrexate, corticosteroids)
• Other biologic immunosuppressants (these should usually not be used together with sarilumab due to increased risk of infection)
• Live vaccines (due to immune suppression)
• Certain medications that are broken down by liver enzymes (CYP450), such as some statins or warfarin, because sarilumab can affect how your body processes these drugs

Always inform your healthcare provider about all the medications and supplements you are taking to avoid potential interactions.

Benefits of Sarilumab

The clinical advantages of using sarilumab include:

• Effective Symptom Relief: Many patients experience significant reductions in pain and swelling.
• Improved Quality of Life: By managing symptoms effectively, patients can engage more fully in daily activities.
• Slowed Disease Progression: Sarilumab can help prevent further joint damage in RA patients.
• Convenient Administration: The subcutaneous injection can be done at home, making it easier for patients to manage their treatment.

Contraindications of Sarilumab

Certain individuals should avoid using sarilumab, including:

• Those with a known hypersensitivity to sarilumab or any of its components.
• Patients with active, serious infections should not use sarilumab, because it can further suppress the immune system.
• Individuals with severe liver disease or significantly elevated liver enzymes should not use sarilumab unless specifically advised by a specialist.
• Pregnant or breastfeeding women should also consult their healthcare provider before using this medication.

Precautions and Warnings

Before starting sarilumab, patients should undergo specific lab tests to assess liver function and screen infections. This often includes screening for tuberculosis and hepatitis before starting treatment. It is crucial to monitor signs of infection during treatment, as sarilumab can increase susceptibility. Patients should also be cautious about receiving live vaccines while on this medication.

FAQs

• What is Sarilumab used for? Sarilumab is primarily used to treat moderate to severe rheumatoid arthritis in adults.
• How is Sarilumab administered? Sarilumab is given as a subcutaneous injection, typically every two weeks.
• What are the common side effects? Common side effects include injection site reactions, upper respiratory infections, headaches, and nausea.
• Can Sarilumab be used in children? Sarilumab may be prescribed for pediatric patients, but the dosage will depend on their weight and should be determined by a healthcare provider.
• What should I do if I miss a dose? If you miss a dose, ask your healthcare provider or pharmacist as soon as you remember for advice. Do not take two doses at the same time to make up for a missed dose.
• Are there any serious side effects? Yes, serious side effects can include increased risk of infections, liver enzyme elevation, and blood clots.
• Can I take other medications with Sarilumab? Always inform your healthcare provider about all medications you are taking, as sarilumab can interact with other drugs.
• Is Sarilumab safe during pregnancy? Pregnant women should consult their healthcare provider before using sarilumab, as its safety during pregnancy is not fully established.
• How long does it take for Sarilumab to work? Some patients may notice improvements within a few weeks, but it can take longer for the full effects to be felt.
• Can I receive vaccines while on Sarilumab? Live vaccines should be avoided while taking sarilumab due to the risk of infection. Inactivated (non?live) vaccines may be given, but you should always check with your healthcare provider first.

Brand Names

Sarilumab is marketed under the brand name Kevzara.

Conclusion

Sarilumab represents a significant advancement in the treatment of rheumatoid arthritis, offering patients a targeted approach to managing their condition. By inhibiting interleukin-6, it helps reduce inflammation and improve overall quality of life. However, as with any medication, it is essential to discuss its use with a healthcare provider to ensure it is appropriate for your specific situation.